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West Nile (WN) virus is the most widespread among flaviviruses, but until recently it was not known on the American
continent. We describe here design of a subgenomic replicon, as well as a full-length infectious clone of the lineage II WN
strain, which appeared surprisingly stable compared to other flavivirus infectious clones. This infectious clone was used to
investigate effects of 59- and 39-nonrelated sequences on virus replication and infectivity of synthetic RNA. While a long
nonrelated sequence at the 39-end delayed but did not prevent establishment of the productive infectious cycle, a much
shorter extra sequence at the 59-end completely abrogated virus replication. Replacement of the conserved 59-adenosine
residue substantially delayed, but did not prevent, establishment of virus infection. In all cases, the recovered virus had
restored its authentic 59- and 39-end genome sequences. However, the presence of extensive nonrelated sequences at both
59- and 39-ends could not be repaired. © 2001 Academic Press
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The Flavivirus genus consists of over 60 closely re-
lated viruses including several human pathogens of
global and local epidemiological importance, with most
of them being transmitted by arthropod vectors. With a
combined toll of hundreds of millions of infections
around the world annually, yellow fever (YF), Japanese
encephalitis (JE), tick-borne encephalitis, and dengue
(DEN) viruses continue to be in the focus of epidemio-
logical surveillance worldwide. While the availability of
an efficient vaccine and control of mosquito vectors have
resulted in substantial improvement of the epidemiolog-
ical situation with yellow fever, other existing as well as
emerging flavivirus-associated diseases, for which vac-
cines are not yet available, continue to challenge exper-
imental virology. Isolated from an infected patient in the
West Nile district of Uganda in 1937 (Smithburn et al.,
1940), West Nile (WN) virus soon was recognized as the
most widespread of the flaviviruses, at that time with a
geographic distribution including four of six continents.
As demonstrated by a recent outbreak of WN fever in
Romania, which involved more than 500 clinical cases
with an almost 10% fatality rate (Hubalek and Halouzka,
1999), this mosquito-borne infection may also occur on a
mass scale in countries with a temperate climate. The
virus was not known in the United States, however, until
its recent sudden appearance in the northeastern part of1 To whom reprint requests should be addressed. Fax: (804) 243-
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294the country (Anderson et al., 1999; Jia et al., 1999; Lan-
ciotti et al., 1999). This caught both health officials and
virologists off-guard, since development of an anti-WN
vaccine was never considered as a priority in the United
States due to the sporadic nature of this disease else-
where. Perhaps for the same reason, an infectious clone
of this virus has not been reported yet, although such
infectious clones have been reported for other flavivirus
pathogens of substantial epidemiological concern (Rice
et al., 1989; Lai et al., 1991; Sumiyoshi et al., 1992; Khro-
mykh and Westaway, 1994; Kapoor et al., 1995; Mandl et
al., 1997; Hurrelbrink et al., 1999).
Flaviviruses are small spherical enveloped viruses
with virions composed of three structural proteins des-
ignated C, M, and E, and a single (1)RNA genome of
about 11,000 nucleotides. Flavivirus genomic RNA is the
only virus-specific messenger RNA in infected cells, en-
coding a single open reading frame constituting roughly
95% of the flavivirus genome. It is translated into a large
precursor, which is processed into structural and non-
structural proteins arranged in the order C-prM-E-NS1-
NS2A-NS2B-NS3-NS4A-NS4B-NS5, where prM denotes
a precursor for the M protein, and NS1 through NS5
represent the nonstructural proteins (Rice, 1996). Produc-
tive virus infection can be initiated upon introduction of
flavivirus genomic RNA into susceptible hosts or cultured
cells (Ada and Anderson, 1959; Stollar et al., 1967). Ac-
cordingly, recovery of flaviviruses from infectious clones
is accomplished by transfection of synthetic (1)RNA
transcripts into susceptible cells to initiate the viral rep-
lication cycle. This approach also proved to be success-
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295WN INFECTIOUS CLONEful in vivo upon injection of synthetic RNA in susceptible
animals (Gritsun and Gould, 1995; Mandl et al., 1998).
Difficulties in assembly of flavivirus infectious clones
due to the pronounced instability of corresponding con-
structs have been reported (Rice et al., 1989; Sumiyoshi
et al., 1992; Gritsun and Gould, 1995; Polo et al., 1997;
Campbell and Pletnev, 2000). For other flaviviruses (Lai
et al., 1991; Khromykh and Westaway, 1994; Hurrelbrink
et al., 1999), single plasmid infectious clone constructs
were assembled in low copy number vectors, at the
expense of high DNA yield. Such constructs may be
defined as “metastable”; an excellent discussion on this
matter can be found in Polo et al. (1997). Such instability
may have created the major obstacle impeding develop-
ment of “infectious DNA,” or DNA/RNA layered con-
structs (Herweijer et al., 1995; Dubensky et al., 1996), for
flaviviruses. The only flavivirus DNA/RNA layered con-
struct has been reported for Kunjin replicons (Varnavski
et al., 2000), which did not include the structural protein
genes.
In the common approach (Rice et al., 1989) currently
used in design of flavivirus infectious clones, the tran-
script 59-end is defined by precise engineering of a
bacteriophage promoter transcription start to the begin-
ning of the viral genome, and an authentic or close to the
authentic 39-end is formed during run-off transcription of
plasmid linearized at the 39-end of the cloned viral cDNA
genome. This is more difficult to implement in design of
flavivirus infectious DNA constructs, since in such a case
formation of transcript 39-ends in vivo is determined by
nuclear mechanisms of mRNA processing and polyade-
nylation and likely will be associated with addition of a
nonrelated sequence at the 39-end of the primary tran-
script.
In the current report we describe design of an infec-
tious clone of WN virus, which in contrast to infectious
clones described for other flaviviruses appeared surpris-
ingly stable. The designed infectious clone may serve as
a basis for studies on rational design of a WN vaccine,
and may be used in elucidation of pathogenic properties
of this virus. Using this infectious clone, we investigated
effects of 59- and 39-nonrelated sequences on the infec-
tious properties of synthetic transcripts. The presented
evidence may be useful in subsequent design of more
convenient flavivirus infectious DNA constructs.
RESULTS AND DISCUSSION
Design of a WN infectious clone
The complete nucleotide sequence of the West Nile
virus genome, strain WN 956 D117 3B (referred below to
as WN 956), which was obtained from Yale Arbovirus
Research Unit through Dr. A. Filipe (Wengler and Gross,
1978), has been determined (Wengler, 1981; Castle et al.,
1985, 1986; Wengler et al., 1985; Wengler and Castle,
1986; Castle and Wengler, 1987). A 59-cDNA fragment of
t
Xthe WN genome (pos. 1–5324), which encoded approxi-
mately half of the polyprotein precursor including 243
N-terminal amino acids of NS3 (the NS3 protease do-
main (Chambers et al., 1990b; Wengler et al., 1991), was
obtained from plasmid pGEM-K (Farber, 1990). This frag-
ment exhibited positional instability; i.e., it displayed a
high propensity for rearrangements when cloned in the
direct, but not in the opposite, orientation downstream
from bacterial promoters, such as the lac promoter
present in many vectors with blue-white selection (Sam-
brook et al., 1989). Similar results were obtained when
we attempted to clone this fragment downstream from
the cytomegalovirus immediate early promoter/enhancer
(Foecking and Hofstetter, 1986), suggesting the presence
of genetic elements encoding products toxic for E. coli.
For constructs containing the cDNA of Japanese enceph-
alitis virus, stabilizing nonsense mutations were often
found in the regions encoding structural proteins prM
and E (Sumiyoshi et al., 1992), thus lending further sup-
port to this suggestion. To avoid accumulation of inacti-
vating mutations, the functional integrity of the cDNA
fragment (pos. 1–5324) of the WN genome was moni-
tored by its transient expression in mammalian cells,
either after its subcloning downstream from the T7 pro-
moter and expression in the vaccinia–T7 polymerase
expression system as described earlier (Yamshchikov
and Compans, 1995) or directly after transfection of iso-
lated CMV-directed constructs in BHK cells. Synthesis
and processing of the C-prM-E-NS1-NS2A-NS2B-NS3243
precursor (Fig. 1a), which is produced during expression
of this fragment, result in secretion of prM and E only in
the presence of the active protease (Yamshchikov and
Compans, 1993). Since the NS3243 protease is encoded at
he end of the fragment, secretion of prM and E indicates
reservation of the ORF throughout the entire fragment.
nfortunately, all CMV-directed constructs selected for
he correct size by restriction analysis have failed to pass
his test (results not shown), indicating accumulation of a
onsense mutation(s) in the WN fragment.
To verify the functional integrity of the remaining part
f the WN genome encoding all nonstructural proteins
ithout possible problems associated with the instability
f the full genome cassette, we first assembled a WN
ubgenomic replicon similar to that described earlier for
unjin virus (Khromykh and Westaway, 1997), which did
ot include the structural protein genes (Fig. 1a). The
eplicon was assembled from WN cDNA fragments
resent in pGEM-K and p32E11 (Farber, 1990), and from
n RT-PCR product as described under Materials and
ethods. In pGEM-K, the WN cDNA fragment was posi-
ioned downstream from the SP6 promoter, but contained
0 nucleotides of nonrelated sequence between the 59-
nd of the WN genome and the SP6 transcription start.
e reengineered the SP6 promoter transcription start tohe beginning of the WN sequence, created a unique
baI site at the 39-end of the WN genome as shown in
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296 YAMSHCHIKOV ET AL.Fig. 1b, and removed a fragment encoding the majority of
C (except for its first 23 amino acids), all prM, and the
ectodomain of E up to the E stop-transfer/NS1 signal
sequence. Synthetic capped RNA made from resulting
pSP6WNrep/Xba (see Figs. 1a and 1b) by run-off tran-
scription with SP6 polymerase produced WN antigen-
positive cells upon electroporation into BHK cells (Fig.
2a). The WN-specific fluorescence could be observed
FIG. 1. Schematic representation of flavivirus genome and constructs
Gene boundaries of individual proteins designated according to Cham
stop-transfer sequences. Below, the replicon-encoding cassette, prese
solid line. (b) Arrangement of the 59- and 39-ends in the WN infectious
in bold. (c, d) Arrangement of the 59- and 39-ends in the WN 59-modified
in preparation of 39-extended templates is located in the vector 329 nt d
ribozyme junction in pT7Eg39dTf (see Materials and Methods for d
39-extended templates and the corresponding fragment sizes are show
FIG. 2. Indirect immunofluorescence analysis of transfected cells.
BHK cells (106) in 100 ml PBS were electroporated at 7.5 kV/cm with 1
mg of synthetic RNA made by run-off transcription of pSP6WNrep/Xba
(a) or pSP6WN/Xba (b) with SP6 polymerase, seeded on coverslips, and
incubated in DMEM with 2% FCS. At indicated time points (hours
post-transfection, hpt), cells were fixed in 5% acetic acid in methanol for
20 min at 220°C, and reacted with anti-WN hyperimmune ascites fluida
f
(ATCC VR-1267AF) followed with goat anti-mouse IgG-fluorescein con-
jugate (both at 1/100 dilution).for several days after electroporation, indicating en-
sued RNA replication and hence proving the functional
integrity of the assembled WN replicon. In contrast,
synthetic RNA made by run-off transcription of the
SP6WNrep(NS5544) template, which contains an incom-
lete NS5 gene, was incapable of replicating and did not
roduce WN-positive cells upon electroporation under
imilar conditions (results not shown). To restore the
tructural protein genes, the corresponding fragment
as transferred from T7WN(NS3243) (Yamshchikov and
ompans, 1995) into pSP6WNrep/Xba resulting in the
inal WN infectious clone construct designated pSP6WN/
ba. Synthetic capped RNA prepared from this construct
y run-off transcription with SP6 polymerase appeared
nfectious (Fig. 2b). WN antigen-positive cells were de-
ected 24 h after electroporation, and increased in num-
er upon further incubation indicating formation of infec-
ious virus and spread of infection. No increase in num-
er of WN antigen-positive cells was observed after
lectroporation with RNA made from pSP6WNrep/Xba,
xcept for a few cell pairs presumably representing
aughter cells. In contrast to similarly designed Kunjin
eplicons (Khromykh and Westaway, 1997), replication of
NA prepared from pSP6WNrep/Xba caused deteriora-
ion of transfected cells, which become evident for WN
n this study. (a) Flavivirus genome is drawn approximately to the scale.
al. (1990a) are shown with thick vertical lines representing signal and
P6WNrep/Xba, which lacks the structural proteins genes, is shown as
SP6WN/Xba. The abbreviated sequence of the WN genome is shown
ucts pSP6(20)WN/Xba (c) and pT7(GG)WN/Xba (d). The NruI site used
eam from the WN genome 39-end. (e) Arrangement of the WN 39-end–d
of the plasmid design); restriction sites used in preparation of theused i
bers et
nt in pS
clone p
constr
ownstrntigen-positive cells by the 4th to 5th day after trans-
ection. However, blind passages of the media sampled
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297WN INFECTIOUS CLONEat various time points from cells transfected with WN
replicon RNA did not produce any cytopathic effect in
fresh BHK cells. This is consistent with inability of sub-
genomic replicons to form infectious progeny (Khromykh
and Westaway, 1997). Virus recovered from the media of
cells transfected with RNA synthesized from the
pSP6WN/Xba template had the same plaque morphology
FIG. 3. Virus growth in mammalian (Vero) and insect (C6/36) cells.
onolayers of Vero (open symbols) or C6/36 (solid symbols) cells were
nfected with either the parent WN 956 virus (squares), or the viruses
ecovered from pSP6WN/Xba (diamonds), or from pSP6WNEg39/Xba
triangles) at m.o.i. 0.1 pfu/cell. Media were sampled as specified under
aterials and Methods, and virus titers (presented as log pfu per 200
ml of inoculum) were determined by plaque assays on BHK cells under
1% methylcellulose overlay.
T
Summary of the Update
Positiona
Sequence No.
M12294 Strain 956
(lineage II) Update
5818 T A
5819 A T
6148b — G CT
6157b T A
6158b A T
6205b T — VYT
6821 T C
8356 C T
8672b A —
8677b — A
10490 — C
10491 — C
a Position in the sequence are given relatively to the updated seque
b Frame shifts resulting in the specified amino acid changes.
c Nucleotide insertion in the 39-untranslated region.on BHK cells as the parent virus. As shown in Fig. 3, the
recovered virus displayed similar growth characteristics
as the parent virus, both on mammalian cells (Vero) and
mosquito (C6/36) cells. Surprisingly, in stark contrast to
the infectious clones of other flaviviruses (Rice et al.,
1989; Lai et al., 1991; Sumiyoshi et al., 1992; Gritsun and
Gould, 1995; Kapoor et al., 1995; Polo et al., 1997; Camp-
bell and Pletnev, 2000), the pSP6WN/Xba plasmid ap-
peared exceptionally stable in E. coli HB101 and could be
isolated in milligram quantities without compromising its
infectious properties. The entire WN genome present in
pSP6WN/Xba has been sequenced and several differ-
ences have been found in the nonstructural protein re-
gion of the genome, which are summarized in Table 1.
These likely constitute sequencing errors present in the
previously published sequence of WN virus strain 956
(GenBank No. M12294), since resulting changes in the
deduced amino acid sequence align perfectly to the
deduced sequences of other WN virus strains (GenBank
Nos. AF206518, AF196835, AF202541), as well as the WN
closest relative, Kunjin virus (GenBank No. D00246).
Effect of nonrelated 59- and 39-terminal sequences on
virus replication
In the standard approach (van der Werf et al., 1986;
Rice et al., 1989), which was also used in design of the
WN infectious clone, the 59-end of transcripts is defined
by precise engineering of the SP6 or T7 promoter tran-
scription start to the beginning of the viral genome. Since
flavivirus genome RNA begins with an absolutely con-
served dinucleotide AG (Rice, 1996), the common prac-
e Sequence #M12294
ino acid
Corresponding sequence in No. AF196835
Strain NY99 (lineage I)
Y 3 I I
TGSEGKNGRTSF
2 VYTMDGEYRLRGEERKNFL
YRLRGEERKNFL
S 3 P P
silent
G 3 WD WD
— Presentc
— Presentc
10962 nt.ABLE 1
s to th
Am
PRTGN
MDGE
M
nce of
omplem
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298 YAMSHCHIKOV ET AL.tice for design of flavivirus templates is to include an
unrelated G nucleotide upstream to ensure more effi-
cient transcription initiation (Rice et al., 1989). The extra
nucleotide does not seem to affect significantly initiation
of viral replication, and it is lost from the genomic RNA of
the viral progeny (Rice et al., 1989). We were interested in
determining the effect of other modifications at the 59-
end on replication of the flavivirus RNA. We prepared two
59-modified templates from the pSP6WN/Xba infectious
clone (Figs. 1c and 1d). In the first construct,
pSP6(20)WN/Xba, a 20-nucleotide unrelated sequence
was present between the SP6 transcription start and the
beginning of the WN genome (Fig. 1c). In the second
construct, pT7(GG)WN/Xba (Fig. 1d), the extra G nucleo-
tide was retained, but the conservative 59-A nucleotide
was also changed to 59-G (i.e., 59-AG to become 59-GG).
Synthetic capped RNA was prepared from the Xba-lin-
earized templates and electroporated into BHK cells, and
RNA replication was monitored by a ribonuclease pro-
tection assay (RPA) at 12-h intervals. As shown in Fig. 4a,
the 20-nucleotide extension completely prevented repli-
cation of synthetic RNA. Accordingly, no WN-positive
cells were detected by indirect immunofluorescence
when transfected cells were followed up to 5 days after
transfection (results not shown). Surprisingly, a low level
signal indicating ensued replication of viral RNA could
be detected by RPA starting from 48 h after transfection
with (G)WN synthetic RNA (Fig. 4a), and 6 days after
transfection virus was recovered with a yield similar to
that of the wild-type virus. RLM-RACE (RNA Ligase Me-
diated Rapid Amplification of cDNA Ends, see Materials
and Methods) performed on virus-specific RNA isolated
from cells 3 days after transfection with (G)WN synthetic
RNA showed that the wild-type sequence at the 59-end of
the WN genome had been completely restored.
Templates for run-off transcription are usually linear-
ized in such a way that the 39-ends of the synthetic RNA
contain no or only a few nucleotides of unrelated se-
quence (Rice et al., 1989; Mandl et al., 1997). In the
current implementation, WN synthetic RNA made from
the Xba-linearized plasmid is effected to contain four
FIG. 4. Accumulation of virus-specific RNA in transfected cells. BHK
(a) the specified constructs (designated in Figs. 1c and 1d) linearized
in six-well plates as described under Materials and Methods, and incub
(hours post-transfection) was analyzed by RPA with 32P-labeled probe c
isolated from BHK cells 48 hours postinfection with the WN 956 virusnucleotides of unrelated sequence resulting from copy-
ing the 59-overhang formed by XbaI digestion (Xba-RNA).The unrelated single-stranded sequence can be re-
moved from the 39-end of the template by treatment with
mung bean nuclease, and the resulting RNA would pos-
sess the authentic 39-end (MBN-RNA). On the other
hand, run-off transcription of the pSP6WN/Xba plasmid,
which was linearized at the unique NruI site located in
the vector 329 nt downstream from WN genome 39-end,
would yield synthetic RNA containing 331 nt of unrelated
sequence (Nru-RNA) at its 39-end. In all three instances,
electroporation of BHK cells with synthetic RNA prepared
from these templates resulted in productive infection, as
assessed by indirect immunofluorescence (results not
shown). However, while MBN-RNA and Xba-RNA did not
differ in infectivity in this assay, in cells transfected with
Nru-RNA the infectious process became apparent by
indirect immunofluorescence after a delay of approxi-
mately 12–18 h. A similar delay was observed when
accumulation of virus-specific RNA in transfected cells
was measured using RPA (Fig. 4b). Accordingly, while the
relative specific infectivities of both MBN- and Xba-RNA
were essentially the same, the presence of the long
unrelated 39-sequence resulted in more than 10-fold re-
duction in the specific infectivity, as observed for Nru-
RNA (3.5 3 105 vs 2.5 3 104 pfu/mg, respectively). Virus
recovered from media harvested from cells transfected
with such “39-extended” RNA was indistinguishable from
the parent virus and from viruses recovered from MBN-
RNA and Xba-RNA, by both phenotype and genotype.
Analysis of the 39-end sequence, which was done using
an adapted RACE-PAT protocol (Salles et al., 1999) after
polyadenylation of total RNA isolated from virus-infected
cells, did not reveal any nonrelated sequence at the viral
RNA 39-end. Interestingly, Nru-RNA prepared from the
(G)WN template appeared noninfectious, as evidenced
by indirect immunofluorescence, RPA, and lack of recov-
ered virus (results not shown).
The above data suggest that for virus recovery from
synthetic transcripts, a greater level of infidelity in tran-
scription termination than in transcription initiation can
be tolerated. It seems unlikely that transcripts prema-
turely terminated close to the authentic 39-end of the WN
06) were electroporated with 1 mg of synthetic RNA made from either
aI or (b) pSP6WN/Xba linearized with the specified enzymes, seeded
DMEM with 2% FCS; 2 mg of total RNA isolated at indicated time points
entary to the first 105 nt of WN genome RNA. WN—2 mg of total RNA
alyzed in the same assay.cells (1
with Xb
ated ingenome were responsible for initiation of the infectious
cycle observed for 39-extended RNA, because this would
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299WN INFECTIOUS CLONEargue against the 12- to 18-h lag period observed in the
indirect immunofluorescence experiments. A plausible
mechanism of 39-end repair may involve progressive
shortening of RNA by host cell exonucleases until the
replication competency of RNA is restored. Alternatively,
the presence of a conservative stem-and-loop structure
at the flavivirus 39-end (Brinton et al., 1986) may contrib-
ute to proper initiation of (2)RNA synthesis on the 39-
extended template. On the other hand, dinucleotides
59-AG and CT-39 located at the ends of flavivirus RNA are
absolutely conserved between members of the genus,
although the functional importance of their complemen-
tarity is unknown. Simultaneous presence of both the 59-
nd the 39-terminal regions was demonstrated to be
mportant for initiation of flavivirus RNA replication ob-
erved in vitro (You and Padmanabhan, 1999), and may
onstitute a crucial component of the mechanism of the
bserved end repair. Such a mechanism may also be
esponsible for restoration of the native 59-end in case of
G)WN synthetic RNA. The lack of infectivity of Nru-RNA
repared from the (G)WN template seems to lend further
upport to the above hypothesis. However, further stud-
es are needed to distinguish between the above alter-
ative mechanisms.
ffect of ribozyme-mediated 39-end formation on
nfectivity of synthetic RNA
Recently, a DNA/RNA layered approach (Herweijer et
l., 1995; Dubensky et al., 1996), also known as “infec-
ious DNA,” has been developed for alphaviruses, which
elies on in vivo transcription of the viral genome cas-
ette from eukaryotic promoters with subsequent initia-
ion of viral RNA replication in cells transfected with
lasmid DNA encoding such a cassette. Despite major
dvantages of this approach, such as the greater stabil-
ty of DNA and the relative simplicity of virus recovery
rotocols, only a few examples of its utilization have
een reported for infectious clones of selected viruses
Semler et al., 1984; Herweijer et al., 1995; Dubensky et
l., 1996; Beard et al., 1999; Almazan et al., 2000). Flavi-
iruses have not been included in this list yet, despite the
uccess with Kunjin replicons (Varnavski et al., 2000),
erhaps due to technical problems associated with de-
ign of flavivirus infectious clones in general. Although
he initial attempts to assemble a WN infectious clone
nder control of an eukaryotic promoter failed, the knowl-
dge of mechanisms involved in 39-end repair may help
n development of flavivirus DNA/RNA layered con-
tructs, once the instability problem is resolved. Because
9-end formation of in vivo transcripts is determined by
uclear mechanisms of mRNA processing and polyade-
ylation, it likely will result in addition of nonrelated
equences, which may interfere with initiation of RNA
eplication. To remove nonrelated sequences, self-cleav-
ge of the hepatitis d virus ribozyme (HDVR) (Fodor et al.,
n
t1999) has been employed in design of Kunjin replicons
(Varnavski et al., 2000) by precise engineering of the
HDVR cleavage site to the 39-end of in vivo transcripts.
Although replication of RNA transcribed in vivo from such
constructs was demonstrated, the importance of self-
cleavage and its contribution to initiation of replication
remain undefined. The reported implementation likely
relies on a slow rate of the self-cleavage reaction, be-
cause rapid cleavage would interfere with RNA transport
due to removal of the poly(A) tail. On the other hand, from
the above evidence initiation of RNA replication directly
from uncleaved transcripts cannot be completely ex-
cluded.
In the context of the present study, we analyzed use of
HDVR for formation of an authentic genome 39-end in
more detail. To provide a better comparison with the
evidence reported for Kunjin replicons (Varnavski et al.,
2000), we redesigned the SP6WN/Xba construct by in-
corporation of a sequence more homologous to the Kun-
jin 39-NTR. Based on alignment of E gene nucleotide
sequences, two WN virus lineages, which diverged up to
29%, have been defined (Berthet et al., 1997). While
Kunjin belongs to lineage I, the WN 956 strain used in
this study belongs to lineage II (Berthet et al., 1997). We
have replaced the last 1438 nt of the WN genome in
SP6WN/Xba with a 1496-nt homologous sequence from
the 39-end of the genome of WN prototype strain Eg101,
of lineage I (Berthet et al., 1997), to obtain a SP6WNEg39/
Xba chimeric construct. The latter fragment encodes the
entire Eg101 39-NTR as well as 287 aa from the carboxy
terminus of NS5. Based on our sequencing analysis
(GenBank No. AF017254), divergence between the 39-
NTR of Eg101 and Kunjin was estimated to be 9%, com-
pared to 19.7% between the WN 956 strain and Kunjin.
This divergence includes a 41-nt deletion and three
smaller deletions, all in the region encompassing the
first 100 nt of Eg101 and Kunjin 39-UTR. As shown in Fig.
3, the chimeric virus recovered from SP6WNEg39/Xba
had growth characteristics similar to that of the parent
virus and the virus recovered from the infectious clone, in
both mammalian and mosquito cells. This is consistent
with the earlier observation that replication was not af-
fected by a 76-nt deletion from the proximal to NS5
region of the Kunjin replicon 39-UTR (Khromykh and
Westaway, 1997). The hepatitis d virus self-cleaving ri-
ozyme sequence was engineered to the 39-end of the
himeric virus genome in a manner similar to that in the
onstruct shown in Fig. 1e, except that the T7 RNA
olymerase transcription terminator Tf was not included
in a resulting SP6WNEg39d cassette. Transcription of
SP6WNEg39d linearized at the NruI site would produce
NA containing 80 nt of ribozyme sequence and followed
y 329 nt of the vector-derived sequence. Ribozyme-
ediated self-cleavage would remove the entire 409-ntonrelated sequence with simultaneous generation of
he authentic genome 39-end. When compared after elec-
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300 YAMSHCHIKOV ET AL.troporation in BHK cells as described above, but in in-
dependent sets of experiments, the relative specific in-
fectivity of this RNA (4.5 3 105 pfu/mg) was found to be
closer to that of Xba-RNA (7 3 105 pfu/mg) than of
Nru-RNA (3.5 3 104 pfu/mg) prepared from XbaI- or NruI-
linearized SP6WNEg39/Xba, respectively. Although this is
not a direct evidence, the observed increase in the spe-
cific infectivity likely indicates ribozyme-mediated re-
moval of the nonrelated sequence. To monitor this cleav-
age directly, a cDNA fragment corresponding to the last
498 nt of the Eg101 genome was subcloned into a p2.0
vector containing the HDVR sequence between the T7
promoter and the Tf terminator. In the resulting
7Eg39dTf construct, the Eg101 genome 39-end was
precisely engineered to the HDVR self-cleavage site in
such a way that linearization of this plasmid with Ecl136
II or XbaI would produce templates carrying different
length extensions after the WN 39-end (Fig. 1e). PAGE
analysis of 32P-labeled run-off transcripts prepared with
7 polymerase from the linearized templates and subse-
uent quantitation of the observed bands indicated that
ven in the optimal configuration with no extra sequence
fter the ribozyme (Ecl136 II digestion), only about 50% of
he transcripts underwent self-cleavage after 60 min total
ncubation at 37°C. The cleavage efficiency decreased to
bout 36 and 3% as the length of a nonrelated sequence
ownstream from the ribozyme increased (Fig. 5, lanes
ba and sc, respectively). This evidence indicates that
FIG. 5. Self-cleavage of hepatitis d ribozyme. 32P-labeled transcripts
were prepared with T7 polymerase from pT7Eg39dTf (Fig. 1e) linear-
ized where specified with the restriction enzymes shown. After 45 min
transcription at 37°C, the reaction mixtures were treated with DNase
for 15 min at 37°C and samples were analyzed by PAGE in the
presence of 8.3 M urea. M, a 100-nt RNA marker; sc, supercoiled
template; Xba, XbaI; Ecl, Ecl136 II; WN39, the 498-nt 39-end fragment of
the WN genome; Tf, T7 polymerase transcription terminator; d, HDVR
fragment.or transcripts generated in vivo from transfected plasmid
NA containing a ribozyme at the 39-end of the flavivirusenome, the rate of HDVR self-cleavage would likely be
low enough for some of the transcripts to be exported to
he cytoplasm prior to cleavage. Although reaction con-
itions used in the above in vitro cleavage assay differ
rom those accompanying transcription in vivo, espe-
ially in regard to the ionic environment, the above re-
ults suggest that nonrelated sequences downstream
rom the ribozyme should be kept at minimal length to
void their interference with the cleavage reaction.
oncluding remarks
In the present report we described for the first time the
onstruction of an infectious clone of West Nile flavivirus,
hich in contrast to infectious clone constructs of other
laviviruses appeared surprisingly stable during routine
aintenance and amplification in E. coli HB101. In con-
ection with the recent outbreak of West Nile encepha-
itis in the metropolitan United States, the availability of
n infectious molecular clone of this virus constitutes an
mportant step toward rational design of an effective
accine against this pathogen. The designed infectious
lone represents lineage II viruses, which, in contrast to
he NY99 strain, were not found in association with
uman or equine outbreaks (Lanciotti et al., 1999).
We also report evidence suggesting involvement of
ither host cell- and/or virus-specific mechanisms in
estoration of intact 59- and 39-ends of flavivirus synthetic
NA. Existence of such mechanisms should greatly sim-
lify the task of creating more convenient layered flavi-
irus infectious DNA/RNA constructs, which rely on less
ccurate eukaryotic transcription initiation and termina-
ion. Direct transfection of infectious DNA into suscepti-
le cells would eliminate the separate step of in vitro
NA synthesis, and the higher stability of DNA (com-
ared to RNA) in connection with recent advancements
f the DNA immunization methodology could open new
pproaches in design of antiviral vaccines and in immu-
ization practice. While initial attempts to design a WN
nfectious clone in the DNA/RNA layered format were
nsuccessful due to the instability problems discussed
bove, we strongly believe that it is worth continuing
tudies in this direction. Based on the evidence reported
ere, current efforts in our group are concentrated to-
ard design and stabilization of flavivirus infectious DNA
onstructs.
MATERIALS AND METHODS
ell culture and viruses
BHK-21 (Bredenbeek et al., 1993) and Vero (ATCC CRL-
586) cells were maintained at 37°C in humidified atmo-
phere containing 5% CO2 in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 5% fetal calf serum
(FCS, Hyclone) and 13 antibiotic–antimycotic mixture
(GIBCO-BRL). Aedes albopictus clone C6/36 (ATCC CRL-
z
s
l
s
m
r
f
G
(
p
p
g
l
b
I
W
P
m
S
A
X
a
S
t
o
d
(
g
X
c
i
s
f
301WN INFECTIOUS CLONE1660) cells were maintained at 28°C in the same media
supplemented with 10% FCS. The WN strain used in this
study was recovered after electroporation of BHK cells
with archival RNA isolated from virus WN 956 D117 3B,
which had been triply plaque-purified in Vero cells and
grown in BHK cells (Wengler and Gross, 1978). The
previous passage history of this virus is unknown. The
Eg101 strain (Hammam et al., 1965) was obtained from
Dr. L. Zeng (CBER, Bethesda, MD) as passage 13 in
suckling mouse brain and was grown in BHK cells. Vi-
ruses recovered from infectious clones (see below) were
prepared in BHK cells. All procedures involving infec-
tious material were performed under Biological Safety
Level 3 containment.
Plasmid construction
DNA was manipulated using standard procedures
(Sambrook et al., 1989) with commercially available en-
ymes. Throughout the study, NIH Guidelines for Re-
earch involving Recombinant DNA Molecules were fol-
owed. E. coli strain HB101 (F2D(gpt-proA)62 leuB6
upE44 ara-14 galK2 lacY1 D(mcrC-mrr) rpsL20(Strr) xyl-5
tl-1 recA13) was used for cloning and maintenance of
ecombinant constructs. Sequencing of PCR and cDNA
ragments and plasmids was done using an ABI 310
enetic Analyzer and an ABI Prizm 377 DNA Sequencer
PE Applied Biosystems, Foster City, CA) using kits sup-
lied by the manufacturer.
Plasmids pGEM-K and p32E11 containing two overlap-
ing cDNA fragments spanning pos. 1–9550 nt of the WN
enome have been described (Farber, 1990). Using over-
apping PCR, the SP6 promoter was reengineered to the
eginning of WN sequence (Fig. 1b) and the ClaI–Bgl-
I SP6-WN59 conjunct fragment was used to replace the
N 59-end fragment in pGEM-K resulting in pSP6WN59.
CR-mediated deletion of a 2150-bp WN genome frag-
ent (pos. 162–2312) from this plasmid resulted in a
P6WNrep59 cassette, which was excised by ClaI and
sp718, and subcloned together with a 4136-bp Asp718–
baI fragment from p32E11 between ClaI and XbaI (cre-
ted in place of SalI) in pBR322 to produce a
P6WNrep(NS5544) cassette. The remaining 1562-bp
fragment encoding the carboxy-terminal part of NS5 and
WN 39-UTR was recovered by RT-PCR of total RNA iso-
lated from cells infected with WN 956 virus and was
joined to the rest of the genome by overlapping PCR with
simultaneous introduction of a unique Xba site at the end
of the WN 39-UTR (Fig. 1b) and mutation of the XbaI site
at pos. 9460.
To restore genes of the structural proteins, a BglII–NsiI
fragment (pos. 89–3509) from T7WN(NS3243) (Yamsh-
chikov and Compans, 1995) was transferred into
pSP6WNrep/Xba resulting in the final WN infectious
clone construct designated pSP6WN/Xba. The 59-modi-
fied versions of this construct (Fig. 1c) were created by
e
wreplacing its ClaI–BglII SP6-WN59 conjunct fragment ei-
her with the similar fragment excised from pGEM-K to
btain pSP6(20)WN/Xba (Fig. 1c) or with the fragment
esigned by overlapping PCR to obtain pT7(GG)WN/Xba
Fig. 1d).
The 1496 bp 39-UTR cDNA fragment of the Eg101
enome present in the chimeric construct SP6WNEg39/
ba was obtained by RT-PCR of total RNA isolated from
ells infected with the Eg101 strain, and was engineered
nto the infectious clone construct replacing the corre-
ponding 1438-bp WN 956 39-end fragment by overlap-
ping PCR. The SP6WNEg39d construct was obtained
after blunt-end insertion of an 82-bp fragment encoding
the HDVR (Fodor et al., 1999), which was excised from
the p2.0 plasmid (Pattnaik et al., 1992) as a SmaI–Ecl136
II fragment. The fragment was inserted into SP6WNEg39/
Xba that was linearized with XbaI and treated with mung-
bean nuclease to remove sticky ends. In this construct,
the HDVR self-cleavage site was precisely engineered to
the 39-end of the WN genome. To create the T7Eg39dTf
template (Fig. 1e), a 498-bp (pos. 10522–11020) 39-end
fragment of the Eg101 genome was amplified from
pSP6WNEg39/Xba and subcloned into SmaI-digested
p2.0.
A cDNA fragment corresponding to the first 105 nt of
the WN genome was amplified by PCR from pSP6WN/
Xba and subcloned into pGEM 3 (Promega, Madison, WI)
in such a way that a (2)RNA probe could be synthesized
by run-off transcription of the linearized template with T7
RNA polymerase.
Synthesis, isolation, and analysis of RNA
Synthetic capped RNA was prepared using run-off
transcription of linearized templates. Ten to twenty mi-
crograms of supercoiled template plasmids was di-
gested to completion with either XbaI or NruI according
to the manufacturer’s protocols, and the reaction mixture
was supplemented with SDS to 0.2% and treated over-
night at 55°C with proteinase K. Following phenol–chlo-
roform deproteinization, DNA was precipitated with alco-
hol and dissolved at 0.5 mg/ml in water. One to two
micrograms of such templates was transcribed with 25 U
of SP6 or T7 RNA polymerase (Epicentre Technologies)
in 50 ml of 13 transcription buffer (Sambrook et al., 1989)
in the presence of 500 mM nucleotide triphosphates, 500
mM cap-analog m7GpppG (New England Biolabs), and
25 U of RNasin (Pharmacia Biothech) for 1 h at 37°C,
following by digestion of the templates with 1 U RNase-
free DNase (Epicentre Technologies) for 10 min at 37°C.
RNA was isolated by overnight incubation at 220°C after
addition of 25 ml of LiCl precipitation solution (Ambion)
ollowing 15 min centrifugation at full speed in a refrig-
rated benchtop centrifuge. The RNA pellet was washed
ith 70% alcohol, redissolved in water, and quantitated
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302 YAMSHCHIKOV ET AL.spectrophotometrically assuming that 1 A260 equals 40
mg/ml.
Total RNA from infected and transfected cells was
isolated using the RNeasy Mini Kit (Qiagen) with DNase
treatment according to the manufacturer’s protocol, and
quantified spectrophotometrically. Ribonuclease protec-
tion assays were performed with the RPA II kit (Ambion),
and a 32P-labeled (2)RNA probe complementary to the
irst 105 nt of WN genome, which was prepared with the
7-MAXIscript kit (Ambion) and [a-32P]UTP (800 Ci/mmol,
EN) according to the manufacturer’s protocols. Two
icrograms of total RNA per sample was used for RPA
ssays.
The sequence at the 59-end of viral RNA was deter-
ined using the RLM-RACE kit (Ambion) according to the
anufacturer’s protocol. Briefly, 5 mg of total RNA from
ransfected cells was dephosphorylated with phospha-
ase, treated with tobacco acid pyrophosphatase to re-
ove the 59-cap structure, and then ligated to the sup-
lied RNA linker in the presence of RNA ligase. Follow-
ng nested RT-PCR using two sets of RNA linker-specific
nd WN-specific primers, a gel-purified fragment was
equenced.
The 39-end sequences of viral RNA were determined
sing an adapted RACE-PAT assay (Salles et al., 1999).
hree to five micrograms of total RNA from infected cells
as polyadenylated in the presence of poly(A) polymer-
se according to the manufacturer protocol. This RNA
as used for cDNA synthesis in the presence of a
T15-anch primer (Salles et al., 1999) and reverse tran-
criptase. Following PCR amplification using the same
T15-anch primer and a second primer corresponding to
t 10468–10485 of the WN genome, a gel-purified frag-
ent was sequenced.
For in vitro analysis of ribozyme cleavage, 32P-labeled
transcripts were prepared from supercoiled, or Ecl136 II-
or XbaI-linearized pT7Eg39dTf (Fig. 1e) using a T7-
AXIscript kit. Transcription was allowed to proceed at
7°C for 45 min, followed by treatment with RNase-free
Nase at 37°C for 15 min. Samples were analyzed on 5%
olyacrylamide gels in the presence of 8.3 M urea, fol-
owed by fixation of gels in 5% acetic acid. Dried gels
ere exposed to X-ray film and directly quantified on a
hosphorImager (Molecular Dynamics). The cleavage
fficiency was calculated as the ratio of radioactivity
ssociated with 498 nt self-cleavage product to the sum
f radioactivity associated with all identifiable products.
NA transfection, virus recovery, and specific
nfectivity assays
BHK cells (106) were electroporated in 100 ml PBS with
mg of synthetic RNA in a 1-mm cuvette using an Electro
Square Porator T280 (BTX, San Diego, CA) with 10 3
2-ms pulses at 7.5 kV/cm. After 10 min recovery, cells
ere diluted 50 times with the growth medium andeeded on 10-mm glass coverslips at approx. 105 cells
per coverslip, and incubated in a CO2 incubator at 37°C.
t various times postelectroporation, coverslips were
rocessed for indirect immunofluorescence, and media
ere saved as a source of recovered viruses.
For evaluation of specific infectivities of mutagenized
onstructs, 106 electroporated cells were either seeded
n 60-mm dishes for bulk virus recovery or used to pre-
are 10-fold dilutions for specific infectivity assays. In the
atter case, serial 10-fold dilutions made by mixing 2 3
04 electroporated cells with 2 3 105 untreated BHK cells
were seeded into separate wells of six-well plates and
cells were allowed to attach for 3–4 h in the CO2 incu-
bator at 37°C and were further incubated under a 1%
methylcellulose overlay for 4 days until development of
visible foci of cytopathology (plaques). Cell monolayers
were fixed with 1% formalin in PBS, and plaques were
visualized by staining with crystal violet.
For RPA assays, half of the electroporated cells after
the recovery period were washed with PBS and used for
isolation of total RNA at time point 0. The rest of the cells
was seeded into 35-mm dishes as four serial twofold
dilutions with the growth media, and the cultures were
incubated for 12–48 h in the CO2 incubator at 37°C. At
12-h intervals, cells were harvested and used for isola-
tion of total RNA.
Viral growth curves were determined by infecting
monolayers of Vero or C6/36 cells with specified viruses
at m.o.i. of 0.1 pfu/cell. Following aspiration of the virus
inoculum, cells were washed with PBS and incubated in
growth medium for up to 5 days in the CO2 incubator at
7 or 28°C. Media were sampled at 12- to 24-h intervals
nd assayed for virus titers. For determination of virus
iters, 2 3 105 BHK cells in six-well plates were infected
in duplicate with 200 ml of serial 10-fold dilutions of virus
samples for 1 h at 28°C with occasional mixing. After
aspiration of virus inoculum, cells were incubated under
the methylcellulose overlays and stained as above.
Detection and analysis of viral proteins
Indirect immunofluorescence assays were used for
detection of WN antigens in transfected cells. Cell mono-
layers grown on glass coverslips were fixed by 5% acetic
acid in methanol at 220°C for 20 min, washed with PBS,
and incubated with 1:100 dilution of WN immune mouse
ascites fluid (AF, ATCC VR-1267 AF) in PBS containing
0.4% BSA for 1 h at ambient temperature, followed by
fluorescein-conjugated goat anti-mouse IgG (GIBCO-
BRL) at 1:100 dilution in the above diluent. After washing,
coverslips were mounted using VectaShield fluores-
cence mounting medium (Vector Laboratories, Burlin-
game, CA) and observed under a fluorescent microscope
equipped with a video imaging system.
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